NASDAQ · DALS
DA32 Life Science Tech Acquisition Corp.
Financial Services · Shell Companies
$10.30
Down-$0.02 (-0.19%)
Updated Oct 12, 2026, 12:46 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 264.2M
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- — – —
- Volume
- 2.25K
- Avg. volume
- 29.22K
Price performance · DALS
DALS price history
1M range · 0 trading sessions · Daily adjusted prices
DALS does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest DALS news
The latest Smart Investors Daily articles mentioning DALS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
DALS research
Overview
Company profile and research snapshot.
Company profile
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
